NCHI (National Coalition for Health Integration) in the USA

December 2009

nchi

The National Coalition for Health Integration (NCHI) is a non-profit organization focused on changing the way health information is shared. 

NCHI Vision: To create a robust, accessible, integrated health information platform that supports the comprehensive management and secure exchange of biomedical data on a national scale.

NCHI Objective: To provide an organizational structure through which the secure, national sharing of biomedical information will be feasible. NCHI seeks to develop collaborations through which the technological, financial and institutional resources needed to share data over a comprehensive, low barrier to entry information platform can be leveraged through economies of scale. NCHI will secure and facilitate the distribution of the necessary resources including funding, technology and partnership to create a new national health network to manage medical data and information that is available to the public and private sectors with the goal of improving health for individuals.


IOM (Institute of Medicine of the National Academies) in the USA

July 2009

Grid Computing and Health Information Sharing: A Platform Proposal

Background
With the U.S.A.'s commitment to universal application of electronic health records, and their expanded use globally, the prospect is at hand for an entirely new resource and approach to the sharing and use of health information for clinical care, public health, and the conduct of clinical research. Several concept, pilots, and operational approaches are currently underway to explore and advance the capacity. With the sponsorship of the Foundation for Translational Science, a meeting was hosted at the National Academies on July 14, 2009, to bring together knowledgeable stakeholders for a discussion of needs, opportunities, current approaches, priority issues, and potential next steps in fostering progress.

Meeting Objectives

  1. Explore the potential for the sharing and use of scientific information and electronically embedded
    clinical data for care enhancement, monitoring and knowledge development.
  2. Review the technical elements, applicability and feasibility of a specific proposed grid
    computing based platform.
  3. Discuss a theoretical test case that will help illustrate the capacity and functionality, in the
    near- and longer-term, of the proposed approach.
  4. Identify and consider commonalities with related activities and proposals in play.
  5. Identify key remaining technical issues related to proof of concept and progress.
  6. Identify follow-up important to advancing concepts and application.

Harris Acquisition

July 2015

Soon-Shiong’s NantHealth Buys Technology Firm
By MARNI USHEROFF Thursday, July 16, 2015

Patrick Soon-Shiong’s health care IT firm NantHealth announced Thursday it has acquired Harris Healthcare Solutions. Terms of the deal were not disclosed, though Soon-Shiong said it is his firm’s largest acquisition to date.

He previously hinted the deal could be the last transaction before NantHealth goes public. Harris’ technology enables health care organizations to integrate data from different sources to give a more complete view of patient information, a big IT challenge in the medical world. NantHealth aims to use patients’ genetic information to craft personalized cancer treatment plans. The firm wants to enable patients, physicians, insurers and others to coordinate that care, provide access to clinical trials, monitor outcomes and control costs in real time.

“The acquisition of Harris Healthcare Solutions, our largest transaction to date, brings unique and proven technology with a large global footprint that significantly furthers our stated goal to improve patient outcomes by efficiently providing physicians with integrated, clinically relevant patient-centric information in real-time.”

— Patrick Soon-Shiong, M.D.

The acquisition should help NantHealth integrate those systems.

Harris, based in Herndon, Va., already works with health systems such as Kaiser Permanente and Cleveland Clinic. The deal will give NantHealth 170 new employees in Cleveland, Phoenix, London, Washington, D.C., and Melbourne, Fla.

The deal follows last month’s announcement that electronic medical records provider Allscripts Healthcare Solutions Inc. had taken a 10 percent stake in NantHealth for $200 million, valuing the NantWorks subsidiary at $2 billion.

At the time, Soon-Shiong didn’t mention Harris by name, but told the Business Journal that after a forthcoming global infrastructure deal, he felt “pretty confident” NantHealth would be ready to go public before year’s end.

For the full report, click here.


NaviNet

Acquisition scales NantHealth's cloud-based platform of services to deliver interoperability, connectivity, real-time decision support and a single sign-on operating system to over 450,000 active provider users and all-payer access to 450+ commercial and government plans nationally, covering almost 100 million lives and over 30 million monthly transactions.

NaviNet Open will serve as a nationwide scalable, real-time access point and secure web-based portal for patients and providers to receive breaking news about novel clinical agents and to access active cancer clinical trials locally.

For the full report, click here


Cancer Breakthroughs 2020

January 2016

Historic National Coalition Formed to Accelerate Next Generation Immunotherapy in Cancer

Large Pharma, Biotech, Major Payer, Fortune 50 Company, Academia and Community Oncologists Join Forces to Announce Launch of Cancer Breakthroughs 2020 Program

  • Nation’s first insurance coverage of next generation whole genome sequencing and proteomic diagnostic platform in cancer patients

  • Next generation sequencing and precision medicine evolving from research to the clinical trial and cancer care setting

  • Coalition to design, initiate and complete randomized clinical trials at all stages of cancer in up to 20 tumor types in as many as 20,000 patients in multiple phase 1 to 3 trials by year 2020

  • Beneficiaries and patients will undergo next-generation molecular sequencing and gain access to over 60 novel and approved molecules to be tested as immunotherapy combinations in 20,000 cancer patients with cancer across all tumor types: The QUILT Program